Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma (AU:RGT)
ASX:RGT
Argent Biopharma (RGT) Share Price & Analysis
2 Followers
RGT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.25 - AU$1.16
Previous CloseAU$0.3
Volume1.01K
Average Volume (3M)10.72K
Market Cap
AU$14.52M
Enterprise ValueAU$14.23M
Total Cash (Recent Filing)AU$239.82K
Total Debt (Recent Filing)AU$575.14K
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.58
Shares Outstanding43,851,631
10 Day Avg. Volume1,492
30 Day Avg. Volume10,721
Standard Deviation0.25
R-Squared0.16
Alpha0.00774
Financial Highlights & Ratios
Price to Book (P/B)-139.36
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Argent Biopharma News
PremiumCompany Announcements
Argent BioPharma Issues 2.5M Shares
PremiumCompany Announcements
Argent Biopharma Expands ASX Securities
PremiumCompany Announcements
Argent Biopharma Plans New Securities Issue
PremiumCompany Announcements
Argent BioPharma Secures Additional $2M Funding
PremiumCompany Announcements
Argent BioPharma Awaits Capital Raising Reveal
PremiumCompany Announcements
Argent BioPharma Director’s Interests UpdatePremiumCompany Announcements
Argent Biopharma Announces Cessation of Securities
PremiumCompany Announcements
Argent Biopharma Issues New Unlisted WarrantsRGT FAQ
What was Argent Biopharma’s price range in the past 12 months?
Argent Biopharma lowest share price was AU$0.25 and its highest was AU$1.16 in the past 12 months.
What is Argent Biopharma’s market cap?
Currently, no data Available
When is Argent Biopharma’s upcoming earnings report date?
Argent Biopharma’s upcoming earnings report date is Aug 28, 2024 which is in 36 days.
How were Argent Biopharma’s earnings last quarter?
Argent Biopharma released its earnings results on Feb 29, 2024. The company reported -AU$30.64 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$30.64.
Is Argent Biopharma overvalued?
According to Wall Street analysts Argent Biopharma’s price is currently Overvalued.
Does Argent Biopharma pay dividends?
Argent Biopharma does not currently pay dividends.
What is Argent Biopharma’s EPS estimate?
Argent Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma have?
Argent Biopharma has 48,405,600 shares outstanding.
What happened to Argent Biopharma’s price movement after its last earnings report?
Argent Biopharma reported an EPS of -AU$30.64 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.5%.
Which hedge fund is a major shareholder of Argent Biopharma?
Currently, no hedge funds are holding shares in AU:RGT
---
Argent Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
14.42%
Trailing 12-Months
Company Description
Argent Biopharma
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
Arrowhead Pharmaceuticals
―
Agios Pharma
―
Alnylam Pharma
―
Amarin
―
Argent Biopharma
―
---